XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Condensed Consolidated Statements of Operations    
PEDMARK product sales, net $ 8,751 $ 7,419
Licensing revenue   17,958
Total net revenues 8,751 25,377
Operating expenses:    
Cost of product sales 373 550
Research and development 94 3
Selling and marketing 2,947 5,209
General and administrative 6,145 5,872
Total operating expenses 9,559 11,634
Net (loss) / Income from operations (808) 13,743
Other (expense)/income    
Unrealized foreign exchange (loss)/gain 13 (38)
Amortization expense (13) (20)
Unrealized loss on securities (1) (11)
Interest income 236 197
Interest expense (592) (1,034)
Total other expense (357) (906)
Net (loss) / income from operations $ (1,165) $ 12,837
Basic net (loss) / income per common share $ (0.04) $ 0.47
Diluted net (loss) / income per common share $ (0.04) $ 0.41
Weighted-average number of common shares outstanding basic 27,578 27,045
Weighted-average number of common shares outstanding diluted 27,578 31,091